Recent Updates
Recently added Catalysts
KPTI Positive Sentiment

Karyopharm to Report Second Quarter 2023 Financial Results on August 2, 2023

Wednesday, July 26, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Karyopharm Therapeutics Inc. is scheduled to report its second quarter 2023 financial results on August 2, 2023. The company will hold a conference call at 8:00 a.m. ET to discuss the results and provide updates. Interested parties can join the call by phone or via a live audio webcast, which will also be archived on the company’s website after the event.
Price reaction · baseline $23.85 (2023-07-25 close) · hit after-hours · clean, no other KPTI news in the window
day 0 close
+8.8%
day 1
+6.3%
day 3 · peak
+13.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Karyopharm Therapeutics is set to announce significant financial results.
  • The conference call will provide updates on company performance and future outlook.
  • Engagement with investors through a live webcast demonstrates transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+105%
120-day peak, hindsight
Typical move
15.1%
average across 5 past catalysts
Cash runway
~8 mo
Medium dilution risk
Lead asset
Selinexor
Phase 2 · Acute Myeloid Leukemia (AML)

Full Press Release Details

-- Conference Call Scheduled for Wednesday, August 2, 2023, at 8:00 a.m. ET --
NEWTON, Mass., July 26, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2023 financial results on Wednesday, August 2, 2023. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Wednesday, August 2, 2023, to discuss the financial results and other company updates.
To access the conference call, please dial (888) 349-0102 (local) or (412) 902-4299 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.

Frequently Asked Questions

When will Karyopharm report its financial results for Q2 2023?

Karyopharm will report Q2 2023 financial results on August 2, 2023.

What time is the Karyopharm conference call scheduled?

The conference call is scheduled for 8:00 a.m. ET on August 2, 2023.

How can I join the Karyopharm conference call?

Dial (888) 349-0102 or (412) 902-4299 at least 10 minutes before the call.

Will there be a webcast of the Karyopharm call?

Yes, a live audio webcast will be available on the company's Investor website.

What trademarks are registered by Karyopharm?

XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics.

ShareAdd on Google
Tags: KPTI Viatris Investor Conferences Healthcare Karyopharm Therapeutics financial results conference call cancer therapies
Last updated: Jul 26, 2023

Biotech snapshot

Cash runway
$65M liquidity · $8M/mo burn
~8 mo
Medium dilution risk
Lead asset
SelinexorPhase 2
Acute Myeloid Leukemia (AML) →

Catalyst track record

+105%
best trade around KPTI's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for KPTI.

See every catalyst's timing & PoA →